Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ectron is a UK medical device company focused on psychiatry, neurology, psychology, and neurorehabilitation. Historically, it pioneered electroconvulsive therapy equipment and today markets the Ectonustim Series 6+ ECT machine for depression treatment. The company also distributes and supports neurotechnology products including transcranial magnetic stimulation systems, robotic rehabilitation devices, functional electrical stimulation systems, and related sensor-based rehabilitation technologies. Its business model appears to center on commercialization, distribution, installation, training, and technical support for hospitals and clinics rather than drug development. For a biotech analyst, Ectron is best characterized as a commercial-stage neurotechnology and medical equipment company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ectron.